Accelerating Gene Design, Strain Optimization, and Bioprocess Control for Next-Generation Biomanufacturing We are committed to advancing synthetic biology through the power of AI... BioSynthAI™’s ...

The number of scientific papers that rely on AI has quadrupled, and the scope of problems AI can tackle is expanding by the ...

Experts share their insights with The i Paper as the UK becomes home to the first major project looking to write human DNA ...

Recursion Pharma has agreed to merge with rival AI-powered drug discovery firm Exscientia in an all-stock deal valued at $688 million ...